Mar 4, 2022
By: Rounak Jain
Credit: BCCL
To raise ₹4,500 crore indirectly via promoters Vodafone Group Plc., and Aditya Birla Group by issuing preferential equity shares at ₹13.3 apiece, which is at a premium of ₹3.3 per share.
Credit: BCCL
Its chairman and managing director have resigned following an open offer by the Burman group to acquire a 26 percent stake in the company.
Credit: Eveready Industries
To issue three right shares for every 10 shares held in the company, at an exercise price of ₹225 per share. The issue opens on March 15 and closes on March 22.
Credit: Wockhardt
Teamed up with development consulting group IPE Global to offer finance facilities worth up to $150 million to health firms, which would otherwise not have access to affordable finance options.
Credit: Axis Bank
Teamed up with NSE to offer unsponsored depository receipts, or NSE IFSC receipts, allowing Indians to invest and trade in US stocks.
Credit: BCCL
Its promoters have reportedly decided to sell the company and part ways.
Credit: UPL
To raise ₹1,856 crore via loans to fund its hydel power project in Himachal Pradesh and a solar power project in Uttar Pradesh.
Credit: SJVN
Received approval from the Drug Controller General of India for its antiviral drug Viralex used in the treatment of COVID-19.
Credit: Themis Medicare
Bagged new orders worth ₹1,131 crore across its businesses.
Credit: KEC International